Auctus Biologics

Lafayette, United States

Auctus Biologics is a biotechnology company that develops antibody mimetics for therapeutic and diagnostic applications.

$229K raised

Feb 2022

Grant

Biotechnology Medical

Top Investors

National Science Foundation Grapeseed.Bio Dennis Sanche

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Auctus Biologics

How much funding has Auctus Biologics raised?

Auctus Biologics has raised $229K in total funding. The most recent round was Grant. The last funding was announced in February 2022.

Who are Auctus Biologics's investors?

Auctus Biologics's investors include National Science Foundation, Grapeseed.Bio, Dennis Sanche.

Where is Auctus Biologics headquartered?

Auctus Biologics is headquartered in Lafayette, United States.

What does Auctus Biologics do?

Auctus Biologics is a biotechnology company that develops antibody mimetics for therapeutic and diagnostic applications.

What stage is Auctus Biologics at?

Auctus Biologics is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 9, 2022.

MLA

"Auctus Biologics — Funding & Investors." VCBacked, February 9, 2022, https://www.vcbacked.co/company/auctus-biologics. Accessed July 2, 2026.

APA

VCBacked. (2022). Auctus Biologics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/auctus-biologics

Wikipedia (cite web)

{{cite web |title=Auctus Biologics — Funding & Investors |url=https://www.vcbacked.co/company/auctus-biologics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 9, 2022.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K